First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.

Schijns, Virgil E J C; Pretto, Chrystel; Devillers, Laurent; Pierre, Denis; Hofman, Florence M; Chen, Thomas C; Mespouille, Pascal; Hantos, Peter; Glorieux, Philippe; Bota, Daniela A; Stathopoulos, Apostolos

Schijns, Virgil E J C; Pretto, Chrystel; Devillers, Laurent; Pierre, Denis; Hofman, Florence M; Chen, Thomas C; Mespouille, Pascal; Hantos, Peter; Glorieux, Philippe; Bota, Daniela A; Stathopoulos, Apostolos.

Affiliation

Schijns VE; Cell Biology & Immunology Group, Wageningen University, PO Box 338, 6700 AH Wageningen, The Netherlands; Epitopoietic Research Corporation (ERC), Namur, Belgium; Epitopoietic Research Corporation (ERC), Schaijk, The Netherlands. Electronic address: Schijns.virgil@gmail.com.
Pretto C; Epitopoietic Research Corporation (ERC), Namur, Belgium; Epitopoietic Research Corporation (ERC), Schaijk, The Netherlands.
Devillers L; Epitopoietic Research Corporation (ERC), Namur, Belgium; Epitopoietic Research Corporation (ERC), Schaijk, The Netherlands.
Pierre D; Epitopoietic Research Corporation (ERC), Namur, Belgium; Epitopoietic Research Corporation (ERC), Schaijk, The Netherlands.
Hofman FM; Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.
Chen TC; Department of Neurosurgery, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA; Epitopoietic Research Corporation (ERC), 1055 E Colorado Blvd., Suite 500, Pasadena, CA 91106, USA.
Mespouille P; Department of Neurology, Arlon Hospital, Arlon, Belgium.
Hantos P; Department of Neurosurgery, Arlon and Libramont Hospital, Arlon and Libramont, Belgium.
Glorieux P; Department of Oncology, Arlon Hospital, Arlon, Belgium.
Bota DA; Department of Neurology/Neurosurgery, University of California at Irvine, UC Irvine Medical Center, Irvine, CA, USA.
Stathopoulos A; Cell Biology & Immunology Group, Wageningen University, PO Box 338, 6700 AH Wageningen, The Netherlands; Epitopoietic Research Corporation (ERC), Namur, Belgium; Epitopoietic Research Corporation (ERC), Schaijk, The Netherlands; Department of Neurosurgery, University of Southern California, Keck

Vaccine ; 33(23): 2690-6, 2015 May 28.

Article de En | MEDLINE | ID: mdl-25865468

Sujet(s)
Mots clés

Allogeneic; Autologous; Glioma; Immunotherapy; Vaccine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunothérapie active / Vaccination / Glioblastome / Médecine de précision Type d'étude: Guideline / Prognostic_studies Limites: Adult / Aged / Animals / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Vaccine Année: 2015 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google